Feng Peng

3.3k total citations
127 papers, 2.0k citations indexed

About

Feng Peng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feng Peng has authored 127 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 44 papers in Oncology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feng Peng's work include Gastric Cancer Management and Outcomes (16 papers), Cancer, Lipids, and Metabolism (15 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Feng Peng is often cited by papers focused on Gastric Cancer Management and Outcomes (16 papers), Cancer, Lipids, and Metabolism (15 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Feng Peng collaborates with scholars based in China, United States and Japan. Feng Peng's co-authors include Jinxiu Lin, Wenquan Niu, Jianxin Jiang, Xingjun Guo, Xiandong Lin, Hejun Zhang, Xiongwei Zheng, Min Wang, Ming Shen and Chengjian Shi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Feng Peng

123 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Peng China 26 952 633 494 414 397 127 2.0k
Jun Jiang China 25 1.1k 1.2× 590 0.9× 429 0.9× 276 0.7× 382 1.0× 113 2.0k
Chun‐Dong Zhang China 26 1.1k 1.2× 600 0.9× 525 1.1× 348 0.8× 462 1.2× 115 2.1k
Yan Xu China 29 1.4k 1.5× 528 0.8× 365 0.7× 539 1.3× 360 0.9× 137 2.9k
Rong Shao China 21 981 1.0× 463 0.7× 730 1.5× 312 0.8× 255 0.6× 58 2.3k
Hongmei Gu China 28 964 1.0× 279 0.4× 362 0.7× 458 1.1× 293 0.7× 96 2.3k
Yabing Chen United States 26 1.2k 1.3× 401 0.6× 337 0.7× 301 0.7× 268 0.7× 54 2.6k
Chunxiao Liu China 27 1.4k 1.4× 635 1.0× 487 1.0× 253 0.6× 365 0.9× 136 2.3k
Kewei Jiang China 27 1.1k 1.1× 770 1.2× 605 1.2× 531 1.3× 459 1.2× 156 2.2k
Jie Tang China 26 1.3k 1.4× 795 1.3× 356 0.7× 186 0.4× 253 0.6× 120 2.2k

Countries citing papers authored by Feng Peng

Since Specialization
Citations

This map shows the geographic impact of Feng Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Peng more than expected).

Fields of papers citing papers by Feng Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Peng. The network helps show where Feng Peng may publish in the future.

Co-authorship network of co-authors of Feng Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Peng. A scholar is included among the top collaborators of Feng Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Peng. Feng Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Laicheng, Lin Mei, Jing You, et al.. (2025). Genetically predicted ankylosing spondylitis increases the risk of heart failure: a Mendelian randomization study. Frontiers in Cardiovascular Medicine. 12. 1415263–1415263.
2.
Deng, Binglu, Jie Shen, Chuqiang Huang, et al.. (2024). Ru doping triggering reconstruction of cobalt phosphide for coupling glycerol electrooxidation with seawater electrolysis. Journal of Energy Chemistry. 100. 317–326. 32 indexed citations
3.
4.
Gong, Jin, et al.. (2023). Comparative Analysis of Single-Path and Multipath Adrenal Venous Sampling in Primary Aldosteronism. Journal of Interventional Cardiology. 2023. 1–8.
5.
Yue, Jiang, Priscilla Wong, Ying Zhang, et al.. (2023). A novel visceral adiposity index predicts bone loss in female early rheumatoid arthritis patients detected by HR-pQCT. Scientific Reports. 13(1). 2471–2471. 2 indexed citations
6.
Liu, Xiuxia, Ye Li, Feng Peng, et al.. (2020). Identification, repair and characterization of a benzyl alcohol-inducible promoter for recombinant proteins overexpression in Corynebacterium glutamicum. Enzyme and Microbial Technology. 141. 109651–109651. 5 indexed citations
7.
Wu, Yuansheng, Meijin Zhang, Changsheng Xu, et al.. (2020). Anti-Diabetic Atherosclerosis by Inhibiting High Glucose-Induced Vascular Smooth Muscle Cell Proliferation via Pin1/BRD4 Pathway. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 13 indexed citations
8.
Li, Linhong, Peng Cheng, Qin Liu, et al.. (2020). lncRNA MSC‐AS1 activates Wnt/β‐catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR‐3924/WNT5A. Journal of Cellular Biochemistry. 121(10). 4085–4093. 38 indexed citations
9.
Shen, Li, Min Xia, Xinzhou Deng, et al.. (2020). A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma. Cellular Oncology. 43(4). 695–707. 21 indexed citations
10.
Yin, Limei, Xiaojuan Zhou, Ruizhan Tong, et al.. (2018). Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancer. Journal of Thoracic Disease. 10(2). 816–824. 11 indexed citations
11.
Lv, Yudan, et al.. (2017). SIRT1 gene polymorphisms and risk of lung cancer. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Zou, Bingwen, Tao Li, Daiyuan Ma, et al.. (2016). Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients. Medicine. 95(17). e3507–e3507. 18 indexed citations
15.
Peng, Feng, Jin Su, Jinxiu Lin, & Wenquan Niu. (2014). Impact of Renin-Angiotensin-Aldosterone System-blocking Agents on the Risk of Contrast-induced Acute Kidney Injury. Journal of Cardiovascular Pharmacology. 65(3). 262–268. 16 indexed citations
16.
Guo, Xingjun, Min Wang, Jianxin Jiang, et al.. (2013). Balanced Tiam1-Rac1 and RhoA Drives Proliferation and Invasion of Pancreatic Cancer Cells. Molecular Cancer Research. 11(3). 230–239. 31 indexed citations
17.
Weng, Zhiyuan, Zheng‐Xiang Li, Yuqiong Li, et al.. (2013). The Association of Four Common Polymorphisms from Four Candidate Genes (COX-1, COX-2, ITGA2B, ITGA2) with Aspirin Insensitivity: A Meta-Analysis. PLoS ONE. 8(11). e78093–e78093. 42 indexed citations
18.
Peng, Feng, Jianxin Jiang, Rui Tian, et al.. (2013). Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. British Journal of Cancer. 109(12). 3092–3104. 88 indexed citations
20.
Zhang, Dong Mei, et al.. (2009). Antitumor and anti‐angiogenesis immunity induced by CR‐SEREX‐identified Xenopus RHAMM. Cancer Science. 101(4). 862–868. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026